Mission and Goal
The fundamental mission of KoDiscovery is to complete the necessary research, including human clinical trials, to make 3-Bromopyruvate (3BP) therapy available for all people with cancer. To further define and differentiate her discovery, she has designated her patented formulation, now 20 years in development, as KoDiscovery Anti-cancer, Anti-infection Therapeutics, or KAAT™. Our broader mission, therefore, is to support the development of treatments and cures for multiple types of cancer, neurological diseases, and other devastating disorders for which no effective therapies are yet known. Ultimately, our mission is to provide relief to those suffering from any health issue, including malnutrition, illness, poverty, lack of basic needs, and other health and human needs that are prevalent around the world.
The goal of KoDiscovery is to become a world leader in the research and delivery of innovative therapies in the field of advanced metabolic and cellular diseases. We will work diligently to ensure that all people with cancer and neurodegenerative diseases have access to the best medical treatments available.